Skip to main content
Atrás
Watch Compare

BIOXYTRAN, INC

Calidad de datos: 83%
BIXT
OTC Manufacturing Chemicals
$0.04
▼ $0.00 (-2.63%)
Cap. Mercado: 4.50 M
Precio
$0.04
Cap. Mercado
4.50 M
Rango del Día
$0.04 — $0.04
Rango de 52 Semanas
$0.03 — $0.20
Volumen
89,500
Apertura $0.04
Promedio 50D / 200D
$0.04
15.53% below
Promedio 50D / 200D
$0.07
46.06% below

Quick Summary

Puntos Clave

Negative free cash flow of -247,174.0

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.00
Interest Coverage-9.44

Valoración

PE (TTM)
-2.13
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -2.1 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -2.11 M
ROE N/A ROA -1391.19%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -247,174.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.00
Interest Coverage -9.44 Asset Turnover N/A
Working Capital -3.05 M Tangible Book Value -3.05 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.13 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5.49%
Market Cap 4.50 M Enterprise Value 4.50 M
Per Share
EPS (Diluted TTM) -0.03 Revenue / Share N/A
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 11.70%
SBC-Adj. FCF -255,590 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -2.37 M -4.28 M -2.46 M -4.53 M -2.54 M
EPS (Diluted) -0.02 -0.03 — — —
Gross Profit — — — — —
Operating Income -2.22 M -3.82 M -2.13 M -4.21 M -1.27 M
EBITDA — — — — —
R&D Expenses 112,337.0 1.15 M 977,768.0 2.01 M 544,519.0
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 84,240.0 — 2.02 M 236,577.0 1.01 M
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 138,694.0 137,638.0 370,936.0 119,290.0 326,403.0
Total Liabilities 1.93 M 3.25 M 3.66 M 3.28 M 2.27 M
Shareholders' Equity -1.79 M -3.11 M -3.29 M -3.16 M -1.94 M
Total Debt 48,000.0 — — — —
Cash & Equivalents — — — — —
Current Assets 5,154.0 26,086.0 295,401.0 72,358.0 316,403.0
Current Liabilities 1.93 M 3.25 M 3.66 M 3.28 M 2.27 M